Newsletter Subject

Aspirin Lowers COVID Death Risk

From

inhresearch.com

Email Address

mail@mb.inhresearch.com

Sent On

Mon, Feb 1, 2021 05:17 PM

Email Preheader Text

 ‌ You need to read this. of a natural substance shown in vitro to be 400 times more effect

 ‌ You need to read this. [Health Watch] Sponsored Content [It’s here!] 1 Daily teaspoon fights diabetes Official government “experts” tell us “no natural substances can manage diabetes.” You can’t fight diabetes with just a daily teaspoon of anything. But Eugene Barclay did. He used just [ONE daily teaspoon]( of a natural substance shown in vitro to be 400 times more effective than Big Pharma’s #1 diabetes drug. All he did was add it to his regular insulin. [teaspoon]( In a matter of weeks—his fasting glucose levels were [SLASHED IN HALF]( compared to insulin alone! Suddenly, Eugene went from a near-death diabetics…to back “in-the-normal-range” in a matter of weeks! What’s more—when he stopped taking it for one week, his blood sugar levels quickly climbed again! Now, even some of the mainstream aren’t even IGNORING this breakthrough—this was no fluke. It’s being called the “[Diabetes-Flusher]( and this is only the beginning of its powers. If you or a loved one is worried about diabetes [click here]( for all of the details. [Click here]( --------------------------------------------------------------- Aspirin Lowers COVID Death Risk If you’re one of the 29 million Americans who take a daily low-dose aspirin, here’s good news… A recent study found that people who take aspirin every day are almost 50% less likely to die from COVID-19. Aspirin is a blood thinner. It can help prevent blood clots. Most people take daily aspirin to prevent a heart attack or stroke, which are often triggered by clots. But researchers at the University of Maryland found an important added benefit. Among hospitalized COVID-19 patients, taking daily aspirin was associated with a: - 44% lower risk of being put on a ventilator - 43% lower risk of being put in intensive care - 47% lower risk of death The study included 412 COVID-19 patients in four different hospitals on the East Coast. All patients were over 55. The aspirin users took a dose of 81 mg a day. This is the standard dosage for someone taking aspirin for heart health. They took aspirin as part of their daily routine before they got sick with COVID and continued to do so after they went into the hospital. --------------------------------------------------------------- Recommended Content Cancer researchers BANNED from studying this breakthrough?! In 1993, archaeologists stumbled on a [mysterious medicine]( hidden in an ancient tomb— But the U.S. government flat-out denied it had any medical value. In fact, they outlawed scientists from studying it—and [banned Americans from using it.]( [archaeologist]( Then it turned up at another archaeological site…and another. Pretty soon, it didn’t matter how loudly the government denied it. There were enough outsiders to confirm: This could have the power to change everything we know about modern medicine. Every American deserves to know the truth. [See it here.]( [Click here]( --------------------------------------------------------------- One of the World’s Oldest Drugs May Combat Its Newest Health Scourge Dr. Michael A. Mazzeffi co-authored the study. He said aspirin may help COVID patients the same way it prevents heart attacks, by thinning the blood. Small blood clots can form in the lungs, heart, and other organs of coronavirus patients, worsening the disease. “We believe that the blood-thinning effects of aspirin provide benefits for COVID-19 patients by preventing micro-clot formation,” Dr. Mazzeffi said. Autopsies have found that patients who died of COVID often had blood clotting in many organs. A study published in The Lancet: Microbe examined 10 deceased coronavirus patients. It found that nine of them had at least one blood clot in a major organ such as the lungs, heart, or kidneys. Some doctors have had success treating COVID-19 patients with powerful blood-thinning drugs such as heparin. These are usually given by injection and can have severe side effects, including serious bleeding. The new study offers hope that aspirin may be a safer alternative. Dr. Jonathan Chow led the study. “If our finding is confirmed, it would make aspirin the first widely available, over-the-counter medication to reduce mortality in COVID-19 patients,” he said. Aspirin is one of the world’s oldest and most-researched drugs. It was first used as a medicine by the ancient Egyptians. Today, between 700 to 1,000 clinical trials are conducted every year to examine aspirin’s effects. Aspirin is generally considered safe. But you may not be able to take daily aspirin if you are at increased risk for bleeding due to ulcers or being on blood-thinning drugs. “The good thing about aspirin is that it’s one of the best-studied drugs in the history of the earth,” Dr. Mazzeffi said. “We know it’s not safe for everyone, but it’s taken by literally hundreds of millions of patients, and it has a great safety profile. “Patients diagnosed with COVID-19 may want to consider taking a daily aspirin as long as they check with their doctor first.” Editor’s Note: Read our monthly newsletter Independent Healing to discover the most-effective, science-backed strategies to stay healthy during the pandemic. Learn about [the vitamin supplement Dr. Fauci is taking… Why one mineral is crucial during the pandemic… How daily aspirin lowers your COVID risk… The natural supplement that outperforms an emergency COVID drug...]( And much more. [Get all the details HERE.]( In Good Health, Amanda Angelini Director The Institute for Natural Healing [References Available Here.]( Related Articles: [Coronavirus: Stop Worrying About Contaminated Surfaces]( [Pandemic Plane Travel May Be Safer Than You Think]( [This Is How You’re Likely to Catch Coronavirus]( --------------------------------------------------------------- © 2021 The Institute for Natural Healing. All Rights Reserved. For more from The Institute for Natural Healing, [visit our website](. To end your free subscription, click here: [Unsubscribe]( Health Watch may be republished with its links intact by non-commercial entities. Health Watch may not be republished for commercial purposes without written permission. This information is offered as a general guideline, not one-size-fits-all medical advice. Talk to your doctor before making any changes in your personal health care regimen. To manage your subscription by mail or for any other subscription issues, write us at: Order Processing Center Attn: Customer Service P.O. Box 925 Frederick, MD 21705 USA

Marketing emails from inhresearch.com

View More
Sent On

11/08/2022

Sent On

11/08/2022

Sent On

11/08/2022

Sent On

10/08/2022

Sent On

10/08/2022

Sent On

09/08/2022

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.